Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (422)

Latest Posts

About This Stock More About This Stock
Most Undervalued Stocks Of The S&P 500 – August 2018
Article By: Benjamin Clark
Monday, August 13, 2018 9:00 PM EDT
Defensive Investors are defined as investors who need to select only the companies that present the least amount of risk. Here are a few companies for the Defensive investors.
In this article: ADS, DUK, LNC, MHK, MS, PRU, TSN, GILD, CFG, SYF
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EDT
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
10 Undervalued Stocks For The Enterprising Investor – August 2018
Article By: Benjamin Clark
Sunday, August 12, 2018 3:01 AM EDT
I’ve selected the ten most undervalued companies. Each company has been determined to be suitable for the Enterprising Investor according to the ModernGraham approach.
In this article: LUCRF, SYF, GILD, PRU, TSN, SLFYF, CFPZF, ITP, KELYA
Read
Week In Review: Shanghai Junshi Biosciences Files For $500 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, August 11, 2018 7:27 PM EDT
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million. Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments.
In this article: SGYP, CELG, GILD, CANF, BGNE
Read
5 Cheap PEG Stocks Suitable For GARP Investors
Article By: Zacks Investment Research
Thursday, August 2, 2018 1:12 PM EDT
Investors seeking long-term growth often wonder whether they should resort to any of the fundamental strategies like growth or value. Going by Warren Buffett, these two approaches are joined at the hip.
In this article: HCA, TMO, BIIB, GILD, QCOM
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments